Literature DB >> 1718062

Conjugated superoxide dismutase reduces extent of caudate injury after transient focal ischemia in cats.

N Matsumiya1, R C Koehler, J R Kirsch, R J Traystman.   

Abstract

We tested the efficacy of preischemic and postischemic systemic treatment with 30,000 units polyethylene glycol-conjugated superoxide dismutase in a reperfusion model of focal cerebral ischemia. Forty-one anesthetized cats underwent 2 hours' occlusion of the left middle cerebral artery and both common carotid arteries followed by 4 hours of reperfusion. Cats were blindly assigned to one of three groups: treatment with vehicle (10% polyethylene glycol in saline, n = 17), pretreatment with drug 3 hours before ischemia (n = 12), and posttreatment with drug at the time of reperfusion (n = 12). Size of the ischemic injury was calculated from 2,3,5-triphenyltetrazolium chloride staining. Injury in the caudate nucleus was significantly reduced with pretreatment (28 +/- 6% of ipsilateral caudate volume, mean +/- SEM) compared with the vehicle (56 +/- 8%). Posttreatment did not significantly ameliorate caudate injury (46 +/- 10%). Between the first and second hours of ischemia ipsilateral caudate blood flow determined using microspheres increased significantly from 11 +/- 4 to 16 +/- 5 ml/min/100 g with pretreatment, but blood flow remained constant throughout ischemia with vehicle (8 +/- 2 ml/min/100 g) and posttreatment (10 +/- 3 ml/min/100 g). The size of cortical injury (vehicle, 17 +/- 5%; pretreatment, 11 +/- 3%; posttreatment, 17 +/- 5% of hemispheric volume) did not differ significantly among groups. Somatosensory evoked potential recovery did not differ among groups. We conclude that pretreatment with conjugated superoxide dismutase can ameliorate the extent of injury in an end-artery region, such as the caudate nucleus, in a reperfusion model of focal ischemia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718062     DOI: 10.1161/01.str.22.9.1193

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant.

Authors:  G B Mackensen; M Patel; H Sheng; C L Calvi; I Batinic-Haberle; B J Day; L P Liang; I Fridovich; J D Crapo; R D Pearlstein; D S Warner
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

2.  Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury.

Authors:  Xiang Yun; Victor D Maximov; Jin Yu; Hong Zhu; Alexey A Vertegel; Mark S Kindy
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-06       Impact factor: 6.200

3.  Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion.

Authors:  P K Liu; C Y Hsu; M Dizdaroglu; R A Floyd; Y W Kow; A Karakaya; L E Rabow; J K Cui
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

4.  Safflor yellow B suppresses pheochromocytoma cell (PC12) injury induced by oxidative stress via antioxidant system and Bcl-2 /Bax pathway.

Authors:  Chaoyun Wang; Hongmei Ma; Shuping Zhang; Yuanfang Wang; Juntian Liu; Xianghua Xiao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-08       Impact factor: 3.000

5.  Safflor Yellow B Attenuates Ischemic Brain Injury via Downregulation of Long Noncoding AK046177 and Inhibition of MicroRNA-134 Expression in Rats.

Authors:  Chaoyun Wang; Hongzhi Wan; Qiaoyun Wang; Hongliu Sun; Yeying Sun; Kexin Wang; Chunxiang Zhang
Journal:  Oxid Med Cell Longev       Date:  2020-06-03       Impact factor: 6.543

6.  Transfusion of Polynitroxylated Pegylated Hemoglobin Stabilizes Pial Arterial Dilation and Decreases Infarct Volume After Transient Middle Cerebral Artery Occlusion.

Authors:  Suyi Cao; Jian Zhang; Li Ma; Carleton J C Hsia; Raymond C Koehler
Journal:  J Am Heart Assoc       Date:  2017-09-12       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.